Eisai

Eisai, a Japanese Pharmaceutical Preparation Manufacturing company, reported Scope 1 emissions of approximately 45,666,000 kg CO2e and Scope 2 (market-based) emissions of around 3,921,000 kg CO2e in 2024. Their Scope 3 emissions, specifically from purchased goods and services, were approximately 825,382,000 kg CO2e for the same year.

Eisai has set ambitious climate commitments, with Science Based Targets initiative (SBTi) validated targets. They are committed to reducing absolute Scope 1 and 2 GHG emissions by 55% by fiscal year 2030, from a fiscal year 2019 base year. Additionally, they aim to reduce absolute Scope 3 GHG emissions from purchased goods and services by 27.5% within the same timeframe. Eisai also has a long-term Net-Zero target, aiming to achieve Net-Zero by 2050. These near-term Scope 1 and 2 targets are classified by SBTi as consistent with reductions required to keep warming to 1.5°C.